Treating Hodgkin's lymphoma
}November 22, 2021
jDr.. Muhannad Al-Khatib

Hodgkin lymphoma cancer treatment

}November 22, 2021
jDr.. Muhannad Al-Khatib

Hodgkin lymphoma cancer treatment

Table of Contents

    Lymphoma is one of the most common cancers in the world, and it is the most common blood cancerIt has two main types, including Hodgkin lymphoma.
    Cancer treatment and diagnosis methods have developed in Turkey to become a destination for many cancer patients around the world.

    Cancer is the proliferation of defective, deformed cells at the expense of healthy cells, and it has serious consequences if treatment is neglected.

     

    What is lymphoma?

    The concept of lymphoma (or what is known as cancer of the lymphocytes), was derived from the cells affected by the disease, which are lymphocytes (a type of white blood cell), especially type B lymphocytes (therefore, it is classified as a blood cancer), where lymph refers to lymphocytes and oma suffix, meaning tumor. Any lymphoma.

     

    Lymphomas usually develop when a change or mutation occurs within lymphocytes, causing the abnormal (neoplastic) cell to multiply faster than normal lymphocytes or to live longer and not undergo programmed cell death (Apoptosis).
    Cancerous lymphocytes can travel through the blood and lymph system and spread and grow in many parts of the body, including the lymph nodes, spleen, bone marrow and many other organs.
     
    Lymphomas are divided into two main categories:
    Hodgkin's lymphoma (it was called Hodgkin's disease): It includes certain cell types characteristic of this disease (we will mention them later).
    Non-Hodgkin lymphoma: These are all tumors that do not fall under the classification of Hodgkin lymphoma.
    Each type spreads, divides and responds to treatment differently, so it is necessary to know which type the patient has to develop the optimal treatment plan, whether for Hodgkin's tumors or non-Hodgkin's tumors.

    Overview of the lymphatic system and lymphocytes

    Before we talk about the pathological or cancerous state of the cells and the lymphatic system, we will mention an overview of the normal physiological state of the lymphatic system and lymphocytes.
     
    The lymphatic system is an important part of the immune system in the human body and it rids the body of many toxins and eliminates many pathogens that attack the body.
    The lymphatic system consists of the lymph, lymph vessels, lymph nodes, bone marrow, spleen, thymus gland, and amygdala.
     
     B and T lymphocytes arise from the bone marrow (which is a primary lymphoid organ) and are initially precursors and then develop into mature lymphocytes in the same bone marrow for type B, while T cells develop in thymus.
    The mature B cells then migrate to the lymph nodes (secondary lymphoid organs) where they gather as follicles in the lymph node cortex.
    Whereas, mature T cells gather in the paracortex.
     
    On the surface of B lymphocytes, there are protein complexes called CD (cluster of differentiation) with different numbers that act as markers that identify the body's cells and help it distinguish different types of cells.
    B cells in the normal state express CD20 and CD45.
    In the event that an antigen is attached to the surface of the B cell, this cell activates, and some of it develops into plasma cells that secrete IgM immunoglobulins, and some of them go to the center of the lymph node and develop into a centroblast, which divides and multiplies and forms what is known as the germ center, where A rearrangement of the immunoglobulin genes for these cells occurs and they become centrocytes, some of which secrete IgA and others IgG.
     

    The centrocytes then differentiate into either plasma cells or memory cells, and the latter circulates in the blood, where part of it remains, or settles in the spleen or in the mucosa-associated lymphoid tissue known as MALT.

    Hodgkin lymphoma treatment

    A glimpse into the lymphatic system to better understand Hodgkin's lymphoma

     
     

    Hodgkin's Lymphoma 

    Hodgkin's disease is a type of lymphoma, named after the English physician Thomas Hodgkin who first described it.
    Hodgkin's lymphoma occurs when the immunoglobulin genes in type B lymphocytes are abnormally rearranged, in which the defective cells divide uncontrollably and become nonfunctional tumor cells.
     
    According to the National Cancer Institute (NCI) in the USA, approximately 9,000 new cases of Hodgkin lymphoma are diagnosed each year.
     Although this cancer can occur in both children and adults, it is more commonly diagnosed in young adults between the ages of 15 and 35 and in older adults over 50.
     
    Hodgkin's lymphoma is less common than non-Hodgkin lymphoma.
     
    Although Hodgkin's lymphoma can start almost anywhere, it most often arises in the upper lymph nodes of the body.
    The most common sites are in the thoracic or cervical nodes or under the arms.
     
    Hodgkin's lymphoma often spreads through the lymphatic vessels, where it travels from one node to another.
    Rarely, in advanced cases, it spreads to extranodal sites through the blood, such as the bone marrow, the lungs, or anywhere in the body.
     

    What is the difference between Hodgkin's lymphoma and non-Hodgkin's?

    The main difference between the two types is the cell arena seen on laboratory examination.
     
    Where distinct cells of Hodgkin lymphoma are seen called Reed-Sternberg cells, which are large multinucleated cells (often arising from the union of two lymphocytes with each other) and give the appearance of owl eyes.
    Reed-Sternberg cells are often surrounded by an inflammatory infiltrate of T lymphocytes. Reed-Sternberg cells activate fibroblasts and eosinophils and secrete cytokines, leading to collagen production, lymphocyte recruitment, and lymph node swelling seen in most patients with Hodgkin's lymphoma.
    We also see Hodgkin's cells, which are large and mononuclear.
     

    There is a difference in the development and spread of the disease between the two types, as we do not see Hodgkin's lymphoma outside the lymph nodes except in rare cases, unlike non-Hodgkin's lymphoma, which is often seen outside the lymph nodes.

    Hodgkin lymphoma treatment

    Reed Sternberg cell seen in Hodgkin lymphoma

     

    Causes and risk factors

    Despite the development of the study of tumor cells and the reason for their emergence in Turkey, the cause of Hodgkin lymphoma remains unclear until now, and various studies and research are still being conducted to find out the reason for this change in the genes of lymphocytes or what triggers the uncontrolled random division.
     
    Some scientists attribute this change in lymphocyte DNA to infection with the Epstein-Barr virus (EBV), but many patients with Hodgkin's lymphoma have not tested positive for this virus.
    Also risk factors are:

    age and gender

    The disease can appear at any age, but the incidence of infection increases in the early adulthood stages (in the twenties) and after the age of 55 years.
    The incidence of infection is slightly higher in males.
     

    A family history of a previous injury

    The association of genetics and the presence of a previous family history with the high incidence of Hodgkin's lymphoma remains a subject of wide debate and controversy.
     
    The incidence of Hodgkin lymphoma increases when there is a brother, sister, father... infected in the family. Some researchers indicate that this rise is due to the exposure of the same family to the same external stimuli (such as the Epstein-Barr virus for example), the presence of some similar genes and many other factors.
     

    weakened immune system

    The incidence of Hodgkin's lymphoma increases in people infected with HIV.
    It also rises in patients taking immunosuppressive drugs.
    As the body's ability to get rid of defective cells is impaired, these causes also lead to a change in the genes of many cells and the occurrence of carcinogenic mutations.
     
    Common infections in children can reduce the incidence of Hodgkin's lymphoma because of the immune changes that occur as a result of these infections.
     

    Symptoms and signs

    Symptoms vary with the severity of the disease and its spread to several lymph nodes, and symptoms usually include:
    • Painless swelling of the cervical, mediastinal, and inguinal lymph node or site of injury.
    • Fever of unknown cause.
    • Profuse night sweats.
    • Unexplained weight loss.
    • itchy skin;
    • Feeling very tired most of the time.
    • Pain in the lymph nodes after drinking alcohol.
    • Cough and other respiratory symptoms.
    Symptoms (weight loss, unexplained fever, night sweats) are the so-called "B symptoms" and are essential in evaluating a patient's cancer stage and in determining the rate of recovery or relapse.
     
    Children can have difficulty breathing, especially when lying down.

    Types of Hodgkin's Lymphoma 

    Hodgkin's cancer is classified into two main types:

    Classical Hodgkin's lymphoma

    It is the most common type and accounts for approximately 93% cases of Hodgkin lymphoma.
    In which the neoplastic cells express CD15 and CD30 instead of the CD20 and CD45 seen in the normal condition.
    There are several types of this type, namely:

    Nodular Sclerosis Hodgkin's Lymphoma

    It is the most common type of classic Hodgkin's carcinoma, with a rate of 80%.
    In this type we see Reed-Sternberg Cells (RSCs) surrounded by normal white cells, and as a result of the activation of fibroblasts by RSCs and collagen production, fibrosis occurs within the affected lymph node, the RSCs here are called Lacunar cells or laconic cells.
     

    Mixed Cellularity Hodgkin's Lymphoma

    The inflammatory (non-neoplastic) infiltrate is composed of eosinophils, neutrophils, and lymphocytes.
     

    Lymphocytes-Rich Hodgkin's Lymphoma

    It is the best warning of these types.
    As the name indicates, lymphocytes are dominant in the inflammatory arena.
     

    Lymphocytes-Depleted Hodgkin's Lymphoma

    It is the rarest and worst warning.
    Where lymphocytes are absent or scarce, with a large number of tumor cells, whether RSCs or Hodgkin's cells.
     
     

    Nodular lymphocyte predominant lymphoma

    It is very rare and often does not present specific symptoms.
    In which the neoplastic cells express CD20 and CD45 in contrast to the classic type.
    In it, the nucleus of the RS cell appears as a cauliflower or a popcorn, so it is called in this type the Popcorn Cell.
     

    Detection of lymphoma in Turkey

    Early detection of the disease did not show any improvement in the cure rate for patients with Hodgkin's lymphoma.
    Several are used Diagnostic methods and tests in Turkey To diagnose Hodgkin lymphoma, including:
    • Pathological history and clinical examination: The symptoms seen in Hodgkin's lymphoma are looked for, and the most common are swollen lymph nodes.
    • complete blood count Complete Blood Count (CBC .) The white cell formula.
    • Several blood tests: LDH, ESR, HIV antibody titer, HCV and HBV antibody titer.
    • Various shooting methods: CT scan, simple chest x-ray, positron emission tomography (PET) scan, magnetic resonance imaging (MRI).
    • Lymph node biopsy: It is used to confirm the diagnosis as the lymph node can swell for several reasons (such as infections), and a biopsy can also determine the type of Hodgkin's lymphoma present in the patient.
    • Bone marrow aspirate or biopsy: They are not used in diagnosing the disease, but in post-diagnosis tests to find out whether the disease has spread to the bone marrow or not and how bad the condition is.
     

    Hodgkin's Lymphoma Staging تقييم

    Determining the stage of lymphoma helps in choosing the appropriate treatment plan, the patient's recovery rate, and the expectation of recurrence after treatment or full recovery.
    The classification of any cancer is a complex process that mainly depends on the experience of the doctor and his ability to choose the appropriate treatment for each patient, so we will not go into detail about the staged assessment too much, but we will mention the main points.
     
    The Lugano Staging classification is used. Based on this classification, Hodgkin's Lymphoma is divided into four stages:

    Stage I

    The disease is present in a single node or group of nodes of one location or in a single lymphoid organ.
     Or the cancer is only present in one part of one organ outside the lymphatic system.

    Stage II

    Cancer is in two groups of lymph nodes either above or below the diaphragm, or has spread to an adjacent organ of the affected node.

    Stage III

    Cancer affects two groups of lymph nodes above and below the diaphragm, or it affects a nodular group above the diaphragm and spleen.

    Stage IV

    The cancer has spread extensively to other organs that are not adjacent to the affected lymph nodes.

    It most commonly spreads to the liver, bone marrow, and lungs.

    Hodgkin lymphoma treatment

    Interim assessment of Hodgkin lymphoma

     

    Hodgkin lymphoma treatment in Turkey

    Hodgkin's lymphoma has a very high rate of cure and improvement compared to other leukemias or even its sister non-Hodgkin lymphoma.
    New treatments in Turkey have achieved rates that exceed expectations in terms of recovery and increased survival, and diagnostic and investigation methods have been developed, and awareness campaigns have spread about this disease.
     
    After successful and effective treatment, patients with Hodgkin's lymphoma can live a long, healthy life with little or no problems.
     
    Hematomas, especially Hodgkin's lymphoma, offer great diversity in the cellular arena and extent of spread, so there are many treatment options and protocols.
     
    Treatment is based mainly on the non-surgical treatment, where the removal of lymph nodes in this disease does not give good results and does not help in curing the disease.
    Surgery may be used for investigational reasons, such as taking a biopsy.
    Splenectomy can be useful in some cases, but this option remains dependent on the doctor's opinion and consideration and whether the patient's general health allows it or not.
     
    Among the most famous and best treatments used in Turkey are:

    Chemotherapy

    It is the preferred and most common treatment for lymphoma, and for Hodgkin lymphoma in particular.
    Give Chemotherapy Either orally or intravenously, as it kills cancer cells or prevents their division, but the drugs given affect any rapidly dividing cell (such as hair cells), which gives many side effects of chemotherapy.
     
    Medicines are given in cycles to relax the body in the period between cycle and cycle, where each cycle lasts a week or several weeks.
     
    Usually, a number of medicines are shared to give better results. We mention the most common share, which is an abbreviation for the first letter of the name of each medicine:
     

    ABVD

    Adriamycin A (doxorubicin), bleomycin B, vinblastine V, dacarbazine (DTIC).
     
    Of course, there are many other posts, but this post is the most popular and most effective.
     
    It should be noted that if the patient is pregnant, we will not be able to protect the fetus from the effects of chemical drugs, and many deformities may occur in the fetus.
    As a result, many clinical trials have been conducted to find out which drugs have the least effect on the fetus.
    Vinblastine has not been found to cause any malformations if given in the last two trimesters of pregnancy.
     

    Immunotherapy

    Aim to Immunotherapy in Turkey To stimulate or help the body's defenses (particularly killer T lymphocytes) to kill and eliminate tumor cells.
    An example is:

    Inhibitory therapy for PD1 and PD-L1

    PD1 is a surface protein found on the surface of killer T cells, and PD-L1 (found on the surface of some tumor cells) binds to PD1 preventing the tumor cell from being destroyed.
    Therefore, this treatment works to inhibit or prevent this association, which helps the immune system to get rid of tumor cells.
     

    Radiotherapy

    Radiation therapy uses high-energy X-rays to kill and destroy tumor cells.
    Radiation therapy is usually combined with other treatments as it is given after or before chemotherapy as required by the patient's condition.
     

    Targeted therapy

    Targeted therapy is one of the most successful, accurate, and least side effects of treatment. It is similar to chemotherapy, except that it is more precise as it targets only tumor cells, making it the preferred option in many cases.
    of its types:

    Antibody-Drug Conjugate (ADC

    It is a synthetic antibodies combined with a chemotherapy drug. The antibodies recognize and bind to surface proteins on the surface of tumor cells such as CD30 (mentioned earlier) and then release the chemical to kill the tumor cell.
    The most famous of these is Brentuximab Vedotin, a compound that is used in many combinations with other chemotherapy drugs to increase the rate of cure and reduce the rate of disease reaction.

    Monoclonal Antibodies

    These are lab-made antibodies that are similar to those of the human immune system and work the same way as ADCs.
    The most famous of these drugs is rituximab.

    Radioimmunotherapy

    This treatment uses monoclonal antibodies loaded with doses of radiation to kill tumor cells.

    radioimmunotherapy

     

    Stem cell transplant (bone marrow transplant)

    This method allows the doctor to give high doses of chemotherapy, which foams at the rate of eliminating tumor cells but destroys the normal cells that produce blood cells, but in this case, after giving a dose of chemotherapy for a certain period, the doctor Injecting stem cells into the bone marrow To replace the destroyed normal cells, thus relieving symptoms and shortage of blood cells.
     
    that Stem Cells They are immature cells that are usually taken from the same patient in an earlier period of his life, and in the absence of them, they can be taken from a person with similar genes (such as a sister, father, or…).
     
     
    As we have seen, the treatment methods are many and complex, and each patient has his own treatment protocol.
     

    Hodgkin's Lymphoma Awareness Month

    In the ninth month of each year, an awareness campaign is conducted to educate patients about Hodgkin's lymphoma, and on the 15th day of this month.
    Describe the symptoms and symptoms of Hodgkin lymphoma patients and encourage regular check-ups for all patients, especially those with some of the above symptoms and high-risk patients.
     
     
     

    Why should I choose treatment in Turkey?

    Turkey is distinguished by the presence of the best hospitals equipped with advanced technologies and a medical staff who has successfully performed this type of operation a large number of times.
    Recently, Turkey has become one of the leading countries in the field of medical tourism in the world, due to the provision of appropriate treatment with advanced centers and at a low cost.
    center Bimaristan Medical It is your first choice For treatment in Turkey.
    We guide you to the best expert specialists in all departments.
    We facilitate the language of communication between you and everyone through specialized Arab doctors who will help you communicate with your doctor.
    We help you secure the right treatment and high-end service in the most modern hospitals and medical centers in Turkey.
    We provide our services extensively and precisely.
    We accompany you step by step towards recovery.
    Free consultations around the clock.
    do not hesitate Contact usBimaristan, your family center in Turkey.

    Frequently asked questions about Hodgkin lymphoma in Turkey

    What is the difference between Hodgkin lymphoma and non-Hodgkin lymphoma?

    The main difference is the type of cells and the spread of cancer outside the lymphatic system. In Hodgkin's lymphoma, we see Reed-Sternberg cells and Hodgkin's tumor cells, and the disease is often limited to the lymphatic system.
    Unlike non-Hodgkin's lymphoma, which is often diagnosed outside the lymphatic system and does not contain precancerous cells.

     

    What is Brentuximab vedotin?

    It is a monoclonal antibody loaded with a chemical drug (Antibody-Drug Conjugate (ADC) and is a quantum leap in the treatment of lymphoma, especially Hodgkin's lymphoma, as it targets surface proteins on the surface of tumor cells and releases the chemical drug to kill them.

    Is lymphoma dangerous?

    Any cancer poses a threat to the patient's life if treatment is neglected. But Hodgkin lymphoma has a high cure rate, especially in Turkey, after the development of diagnostic and treatment methods significantly in its hospitals.

    Table of Contents

      Related Posts

      non-Hodgkin lymphoma cancer treatment

      non-Hodgkin lymphoma cancer treatment

      Non-Hodgkin's lymphoma is the most common lymphatic cancer, and it appears in many extra-lymphatic types, and its diagnosis and treatment requires the best and most skilled hands of Turkish doctors. What is lymphoma? The concept of lymphoma is derived from the cells affected by the disease, which are lymphocytes (a type of blood cell...

      read more
      Bone marrow biopsy - procedure and interpretation of results

      Bone marrow biopsy - procedure and interpretation of results

      A bone marrow biopsy is a medical procedure to collect and examine a sample of bone marrow (spongy tissue inside the bones). Doctors may need a bone marrow biopsy if they suspect some types of cancer or blood diseases. In this article, learn about bone marrow biopsy, why it is performed, how, its harms, and the interpretation of the results of the biopsy in Turkey.

      read more
      Share This